Accele BioPharma, Inc. — Form D
Accele BioPharma, Inc. of OKLAHOMA CITY, OK, a company, filed a Form D exempt-offering notice with the SEC on 2012-09-04. The offering totals $2.6M, of which $2.6M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2012-09-04
- Form: D
- Accession: 0001556986-12-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $2.6M
- Amount sold: $2.6M
- Investors: 6
- Security types: equity
- Revenue range: Decline to Disclose
Issuer
- Name: Accele BioPharma, Inc.
- CIK: 0001556986
- Entity type: Corporation
- Jurisdiction: OKLAHOMA
- Incorporated: 2012
- Address: 655 RESEARCH PARKWAY, OKLAHOMA CITY, OK, 74104
- Phone: 919-360-7010
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Clayton Duncan | Director | Oklahoma City, OK |
| CARL EDWARDS | Director | Oklahoma City, OK |
| Stephen Prescott | Director | Oklahoma City, OK |
| Clayton Duncan | Executive Officer | Oklahoma City, OK |
More